{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:32:03Z","timestamp":1774312323892,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["nmcd-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.numecd.2018.12.008","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T14:02:49Z","timestamp":1546524169000},"page":"334-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["GDF15 reflects beta cell function in obese patients independently of the grade of impairment of glucose metabolism"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7972-7610","authenticated-orcid":false,"given":"M.H.","family":"Schernthaner-Reiter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.K.","family":"Itariu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Promintzer-Schifferl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.M.","family":"Stulnig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.H.","family":"Anderwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Clodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Ludvik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Pacini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Luger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1918-1959","authenticated-orcid":false,"given":"G.","family":"Vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2018.12.008_bib1","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1373\/clinchem.2012.201210","article-title":"Change in growth differentiation factor 15 concentrations over time independently predicts mortality in community-dwelling elderly individuals","volume":"59","author":"Eggers","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.numecd.2018.12.008_bib2","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1136\/heartjnl-2015-308949","article-title":"Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes","volume":"102","author":"Resl","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.numecd.2018.12.008_bib3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1373\/clinchem.2016.255174","article-title":"Growth differentiation factor 15 as a biomarker in cardiovascular disease","volume":"63","author":"Wollert","year":"2017","journal-title":"Clin Chem"},{"key":"10.1016\/j.numecd.2018.12.008_bib4","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1373\/clinchem.2012.190322","article-title":"Clinical and genetic correlates of growth differentiation factor 15 in the community","volume":"58","author":"Ho","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.numecd.2018.12.008_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1373\/clinchem.2010.153726","article-title":"The relationship between insulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients","volume":"57","author":"Vila","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.numecd.2018.12.008_bib6","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4093\/dmj.2014.38.6.472","article-title":"GDF15 is a novel biomarker for impaired fasting glucose","volume":"38","author":"Hong","year":"2014","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.numecd.2018.12.008_bib7","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","article-title":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily","volume":"94","author":"Bootcov","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.numecd.2018.12.008_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.atherosclerosis.2016.02.013","article-title":"Relations of circulating GDF-15, soluble ST2, and troponin-I concentrations with vascular function in the community: the Framingham Heart Study","volume":"248","author":"Andersson","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2018.12.008_bib9","doi-asserted-by":"crossref","first-page":"490842","DOI":"10.1155\/2015\/490842","article-title":"GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective","volume":"2015","author":"Adela","year":"2015","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.numecd.2018.12.008_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/gly153","article-title":"Human aging and longevity are characterized by high levels of mitokines","author":"Conte","year":"2018","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.numecd.2018.12.008_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.tem.2018.05.002","article-title":"Uniting GDF15 and GFRAL: therapeutic opportunities in obesity and beyond","author":"Mullican","year":"2018","journal-title":"TEM (Trends Endocrinol Metab)"},{"key":"10.1016\/j.numecd.2018.12.008_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/nm.4394","article-title":"GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand","author":"Yang","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.numecd.2018.12.008_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/nm.4393","article-title":"The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL","author":"Emmerson","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.numecd.2018.12.008_bib14","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1530\/EJE-12-0466","article-title":"Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial","volume":"167","author":"Kempf","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.numecd.2018.12.008_bib15","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000338729","article-title":"The impact of type 2 diabetes on circulating adipokines in patients with metabolic syndrome","volume":"5","author":"Schindler","year":"2012","journal-title":"Obes Facts"},{"key":"10.1016\/j.numecd.2018.12.008_bib16","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1373\/clinchem.2016.257212","article-title":"GDF-15 is associated with cancer incidence in patients with type 2 diabetes","volume":"62","author":"Pavo","year":"2016","journal-title":"Clin Chem"},{"key":"10.1016\/j.numecd.2018.12.008_bib17","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/ijo.2014.27","article-title":"NAG-1\/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism","volume":"38","author":"Chrysovergis","year":"2014","journal-title":"Int J Obes"},{"key":"10.1016\/j.numecd.2018.12.008_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1083\/jcb.201607110","article-title":"Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis","volume":"216","author":"Chung","year":"2017","journal-title":"J Cell Biol"},{"key":"10.1016\/j.numecd.2018.12.008_bib19","doi-asserted-by":"crossref","first-page":"e65549","DOI":"10.1371\/journal.pone.0065549","article-title":"Adaptive induction of growth differentiation factor 15 attenuates endothelial cell apoptosis in response to high glucose stimulus","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2018.12.008_bib20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1530\/EJE-16-0550","article-title":"Growth differentiation factor 15 increases following oral glucose ingestion: effect of meal composition and obesity","volume":"175","author":"Schernthaner-Reiter","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.numecd.2018.12.008_bib21","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1111\/dom.13311","article-title":"Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: results from the ADVANCE-ON study","volume":"20","author":"Radholm","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.numecd.2018.12.008_bib22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1521-690X(03)00042-3","article-title":"Methods for clinical assessment of insulin sensitivity and beta-cell function","volume":"17","author":"Pacini","year":"2003","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"10.1016\/j.numecd.2018.12.008_bib23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2337\/diacare.24.3.539","article-title":"A model-based method for assessing insulin sensitivity from the oral glucose tolerance test","volume":"24","author":"Mari","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2018.12.008_bib24","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1464-5491.2009.02841.x","article-title":"Evaluation of proposed oral disposition index measures in relation to the actual disposition index","volume":"26","author":"Retnakaran","year":"2009","journal-title":"Diabet Med"},{"key":"10.1016\/j.numecd.2018.12.008_bib25","first-page":"744","article-title":"Pancreatic beta-cell responsiveness during meal tolerance test: model assessment in normal subjects and subjects with newly diagnosed noninsulin-dependent diabetes mellitus","volume":"83","author":"Hovorka","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2018.12.008_bib26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1530\/EJE-16-0528","article-title":"Biomarkers of subclinical inflammation and increases in glycaemia, insulin resistance and beta-cell function in non-diabetic individuals: the Whitehall II study","volume":"175","author":"Herder","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.numecd.2018.12.008_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00125-003-1263-9","article-title":"San Antonio metabolism s. Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study","volume":"47","author":"Gastaldelli","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2018.12.008_bib28","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1158\/1078-0432.CCR-03-0165","article-title":"Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers","volume":"10","author":"Koopmann","year":"2004","journal-title":"Clin Cancer Res"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475318303648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475318303648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T07:52:45Z","timestamp":1553068365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475318303648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0939475318303648"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2018.12.008","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GDF15 reflects beta cell function in obese patients independently of the grade of impairment of glucose metabolism","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2018.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}